Literature DB >> 11945117

Applications of peptide mimetics in cancer.

V Apostolopoulos1, J Matsoukas, M Plebanski, T Mavromoustakos.   

Abstract

The development of a vaccine for cancer has been difficult compared to the effective vaccines of infectious diseases. Most tumor antigens are not entirely foreign and are expressed on normal tissues, thus, making it difficult to induce strong immune responses against self antigens. A peptide mimic, however, may have the potential to generate greater immune responses than those induced to self peptides. In this review we discuss applications of peptide mimics for cancer immunotherapy which may ultimately prove useful in humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11945117     DOI: 10.2174/0929867023370969

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  3 in total

1.  Enhanced major histocompatibility complex class I binding and immune responses through anchor modification of the non-canonical tumour-associated mucin 1-8 peptide.

Authors:  Eliada Lazoura; Jodie Lodding; William Farrugia; Paul A Ramsland; James Stevens; Ian A Wilson; Geoffrey A Pietersz; Vasso Apostolopoulos
Journal:  Immunology       Date:  2006-11       Impact factor: 7.397

2.  Mannan-mediated gene delivery for cancer immunotherapy.

Authors:  Choon K Tang; Jodie Lodding; Gabriela Minigo; Dodie S Pouniotis; Magdalena Plebanski; Anja Scholzen; Ian F C McKenzie; Geoffrey A Pietersz; Vasso Apostolopoulos
Journal:  Immunology       Date:  2007-03       Impact factor: 7.397

3.  An index for characterization of natural and non-natural amino acids for peptidomimetics.

Authors:  Guizhao Liang; Yonglan Liu; Bozhi Shi; Jun Zhao; Jie Zheng
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.